Adviye Ergul to Receptor, Endothelin B
This is a "connection" page, showing publications Adviye Ergul has written about Receptor, Endothelin B.
Connection Strength
2.872
-
Endothelin and diabetic complications: a brain-centric view. Physiol Res. 2018 06 27; 67(Suppl 1):S83-S94.
Score: 0.596
-
Late dual endothelin receptor blockade with bosentan restores impaired cerebrovascular function in diabetes. Life Sci. 2014 Nov 24; 118(2):263-7.
Score: 0.438
-
Endothelial endothelin B receptor-mediated prevention of cerebrovascular remodeling is attenuated in diabetes because of up-regulation of smooth muscle endothelin receptors. J Pharmacol Exp Ther. 2011 Apr; 337(1):9-15.
Score: 0.354
-
Evidence for vasculoprotective effects of ETB receptors in resistance artery remodeling in diabetes. Diabetes. 2007 Nov; 56(11):2753-8.
Score: 0.280
-
Porphyromonas gingivalis infection upregulates the endothelin (ET) system in brain microvascular endothelial cells. Can J Physiol Pharmacol. 2022 Jul 01; 100(7):679-688.
Score: 0.194
-
Diabetes-related sex differences in the brain endothelin system following ischemia in vivo and in human brain endothelial cells in vitro. Can J Physiol Pharmacol. 2020 Sep; 98(9):587-595.
Score: 0.173
-
Dual endothelin receptor antagonism with bosentan reverses established vascular remodeling and dysfunctional angiogenesis in diabetic rats: relevance to glycemic control. Life Sci. 2014 Nov 24; 118(2):268-73.
Score: 0.110
-
Comparison of selective versus dual endothelin receptor antagonism on cerebrovascular dysfunction in diabetes. Neurol Res. 2011 Mar; 33(2):185-91.
Score: 0.090
-
Glycemic control prevents microvascular remodeling and increased tone in type 2 diabetes: link to endothelin-1. Am J Physiol Regul Integr Comp Physiol. 2009 Apr; 296(4):R952-9.
Score: 0.078
-
Impaired insulin-mediated vasorelaxation in a nonobese model of type 2 diabetes: role of endothelin-1. Can J Physiol Pharmacol. 2008 Jun; 86(6):358-64.
Score: 0.074
-
Effect of chronic and selective endothelin receptor antagonism on microvascular function in type 2 diabetes. Am J Physiol Heart Circ Physiol. 2008 Jun; 294(6):H2743-9.
Score: 0.074
-
Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes. Am J Physiol Regul Integr Comp Physiol. 2008 Apr; 294(4):R1213-9.
Score: 0.073
-
Differential effects of ET(A) and ET(B) receptor antagonism on oxidative stress in type 2 diabetes. Vascul Pharmacol. 2007 Aug-Sep; 47(2-3):125-30.
Score: 0.069
-
Saphenous vein endothelin system expression and activity in African American patients. Arterioscler Thromb Vasc Biol. 2002 Jul 01; 22(7):1122-7.
Score: 0.049
-
Endothelin-1 and endothelin receptor antagonists as potential cardiovascular therapeutic agents. Pharmacotherapy. 2002 Jan; 22(1):54-65.
Score: 0.048
-
Selective downregulation of endothelin-B receptors in diabetic African-American patients. Ethn Dis. 2002; 12(1):S1-46-50.
Score: 0.048
-
A review of endothelin and hypertension in African-American individuals. Ethn Dis. 2001; 11(4):741-8.
Score: 0.044
-
Hypertension in black patients: an emerging role of the endothelin system in salt-sensitive hypertension. Hypertension. 2000 Jul; 36(1):62-7.
Score: 0.043
-
Interleukin-10 attenuates vascular responses to endothelin-1 via effects on ERK1/2-dependent pathway. Am J Physiol Heart Circ Physiol. 2009 Feb; 296(2):H489-96.
Score: 0.019
-
Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension. J Sex Med. 2008 Dec; 5(12):2793-807.
Score: 0.019